Microfluidic Devices: Integrated Microfluidic Device for Drug Studies of Early C. Elegans Embryogenesis (Adv. Sci. 5/2018)
Source abstract
Abstract
The feasibility of time-controlled and reversible drug delivery to Caenorhabditis elegans (C. elegans) embryos immobilized on-chip is demonstrated by regulated blocking of cytokinesis using Cytochalasin-D. In article 1700751 by Martin A. M. Gijs and co-workers, the implementation of versatile microfluidic protocols, including time-controlled and reversible drug delivery to on-chip, immobilized embryos, demonstrates the potential of the reported device for biochemical and pharmacological assays.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laboratory of Microsystems Ecole Polytechnique Fédérale de Lausanne (EPFL) Lausanne 1015 Switzerland
Swiss Institute for Experimental Cancer Research (ISREC) School of Life Sciences Ecole Polytechnique Fédérale de Lausanne (EPFL) Lausanne 1015 Switzerland
References
Reference metadata was not supplied for this record.